Tartaric Acid
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 | C4H6O6 | 1g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Sigma Aldrich Fine Chemicals Biosciences Sodium tartrate dihydrate United States Pharmacopeia (USP) Reference Standard | 6106-24-7 | MFCD00150035 | 4X500MG
Sodium tartrate dihydrate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 230.08 | 6106-24-7 | MFCD00150035 | 4X500MG
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 g/mol | C4H6O6 | 1mL
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC DL-Tartaric acid | 133-37-9 | 98.0% | 150.09 | C4H6O6 | 500g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Medchemexpress LLC ENMD-2076 | 934353-76-1 | 99.99% | 375.47 | 10 MG
ENMD-2076 is a multi-targeted kinase inhibitor, demonstrating significant activity against Aurora A, Flt3, KDR/VEGFR2, and other kinases. It effectively inhibits cellular autophosphorylation and induces G2-M-phase arrest and apoptosis in various cell lines. In vivo studies show dose-dependent inhibition of tumor growth and tumor regression, with the compound being well tolerated.
- Inhibits multiple kinases including Aurora A, Flt3, VEGFR2
- Induces G2-M-phase arrest and apoptosis
- Demonstrates antiproliferative activity against human cell lines
- Inhibits cellular Flt3 ligand (FL)-induced Flt3 autophosphorylation
- Inhibits stem cell factor (SCF)-induced Kit autophosphorylation
- Inhibits VEGFR2/KDR autophosphorylation
- Leads to dose-dependent inhibition of tumor growth in vivo
Medchemexpress LLC Tartaric acid (sodium hydrate) | 6131-98-2 | MFCD00150038 | 190.08 g/mol | C4H7NaO7 | 500 G
Tartaric acid sodium hydrate is the sodium salt hydrate of L-(+)-tartaric acid supplied as a white to off-white crystalline solid for laboratory and food-related applications. It is used as an endogenous metabolite reagent and described as a food additive; product documentation including SDS and COA is provided by the supplier.
Sigma Aldrich Fine Chemicals Biosciences DL-Tartaric acid | 133-37-9 | MFCD00071626
DL-Tartaric acid | Purity: 99% | MW: 150.09 | 133-37-9 | MFCD00071626
Medchemexpress LLC Tartaric acid disodium dihydrate | 6106-24-7 | 98.0% | 100 G
Tartaric acid disodium dehydrate (L-(+) -tartaric acid) is an orally active weak organic acid that can be isolated from grapes. It has vasodilatory and antihypertensive effects. This product can be used as flavorings and antioxidants in a range of foods and beverages. It also finds applications in laser frequency doubling and optical limiting.
- Orally active weak organic acid.
- Can be isolated from grapes.
- Has vasodilatory effects.
- Has antihypertensive effects.
- Used as flavorings in foods and beverages.
- Used as antioxidants in foods and beverages.
- Used in laser frequency doubling applications.
- Used in optical limiting applications.
Medchemexpress LLC HY-N2522 5mg Medchemexpress, Carboxyatractyloside (dipotassium) CAS:33286-30-5 Purity:>98%
Medchemexpress, HY-N2522 5mg Carboxyatractyloside (dipotassium) CAS:33286-30-5 Carboxyatractyloside dipotassium is a toxic natural product, acts as an inhibitor of ADP/ATP carrier, inhibits mitochondrial ADP/ATP transport. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC DL-tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 | C4H6O6 | 25g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]